General Info
Dr. Alexey Wolfson, the Co-Founder and Chief Scientific Officer of Mirimmune, has a focus on RNAi technology and nucleic acid biochemistry. His previous investments include Advirna, where he developed RNAi delivery technologies. There is no specific information available regarding his investment check size, stage of investment, geographical preference, track record, professional career, or partnership and collaboration styles at this time.
Location: Cambridge, MA
Country: Russian Federation
Industries:
Investment Regions: EA, SA
Investment Stages: pre-seed, seed
angel-individual
EA, SA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: Searches for Alexey Wolfson (Advirna/MirImmune) returned company and profile pages but no records of him making investments or any dated investment events. The only company noted is Advirna as his company and MirImmune mentioned in profiles; no investment transactions or recent funding checks were found. Therefore defaulting to not-found.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Alexey Wolfson
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI